Rheumatic diseases, glucocorticoid treatment and bone mass: Recent developments

M. Mazzantini, Nancy E Lane

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Recent research has made striking advances, adding to our understanding of the aethiopathogenesis of several forms of secondary osteoporosis, including those associated with rheumatic diseases and glucocorticoid treatment. Furthermore, in the last 3 years new drugs have been shown to prevent glucocorticoid-induced bone loss. Guidelines that are suitable for clinical practice have been published. Knowledge of those new opportunities and strategies, which are briefly reviewed in this article, will reduce the risk of osteoporotic fractures in rheumatic and non-rheumatic patients.

Original languageEnglish (US)
JournalClinical and Experimental Rheumatology
Issue number5 SUPPL. 21
StatePublished - 2000
Externally publishedYes


  • Glucocorticoids
  • Osteoporosis
  • Prevention
  • Rheumatic diseases
  • Treatment

ASJC Scopus subject areas

  • Immunology
  • Rheumatology


Dive into the research topics of 'Rheumatic diseases, glucocorticoid treatment and bone mass: Recent developments'. Together they form a unique fingerprint.

Cite this